Home > Insider Trading > Filing (0000711377-19-000058)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1168789	L James Herbert	Neogen Corp 620 Lesher Place Lansing MI 48912		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-11-21	13,135	$60.43	200,105	No	4	M	Direct
Common Stock	Disposition	2019-11-21	13,135	$65.28	186,970	No	4	S	Direct
Common Stock	Disposition	2019-11-22	20,000	$65.28	187,311	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right to Buy)	Disposition	2019-11-21	13,135	$0.00	13,135	$60.43

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
135,999		2022-11-27	No	4	M	Direct

Footnotes

options were granted 10/27/2017, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grants
Shares were sold under the terms of a Rule 10b5-1 plan filed by the Reporting Person on October 1, 2019
160,209 shares are held in limited liability companies in which Mr. Herbert and his spouse have limited financial ownership. Mr. Herbert and his spouse own 39,568 shares jointly; 7,434 shares are held in trust for Mrs. Herbert, and an additional 100 shares are held in a charitable remainder trust in which Mr. Herbert and his spouse are trustees and beneficiaries.